2024-09-03 - Analysis Report
## PM Stock Analysis Report

**Company Overview:** PM is a leading pharmaceutical company that develops and markets a wide range of prescription drugs.

**1. Performance Comparison:**

* **Cumulative Return:** PM's cumulative return of 60.65% is lower than the S&P 500 (VOO) cumulative return of 89.66%.
* **Lag:** The current lag is -29.01%, indicating PM has underperformed the S&P 500 by 29.01%. The relative lag of 36.88% suggests that the current lag is relatively lower than the past 36.88% of the time.

**2. Recent Price Movement:**

* **Closing Price:** $123.29
* **5-Day Moving Average:** $122.41
* **20-Day Moving Average:** $118.63
* **60-Day Moving Average:** $110.01

The stock price is currently trading above all three moving averages, suggesting an upward trend.

**3. Technical Indicators:**

* **RSI:** 91.57 - The RSI is above 70, indicating an overbought condition.
* **PPO:** 0.01 - The PPO is slightly positive, suggesting a weak buying pressure.
* **Delta_Previous_Relative_Divergence:** -3.87 - This indicates a recent downward trend in the relative divergence, suggesting a potential short-term price correction.
* **Expected Return:** 14.05% - This represents the potential 5-year expected return on the investment, assuming a consistent investment strategy.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-25 | 1.54 | 9.47 B$ |
| 2024-04-26 | 1.38 | 8.79 B$ |
| 2023-10-26 | 1.32 | 9.14 B$ |
| 2023-07-27 | 1.01 | 8.97 B$ |
| 2024-07-25 | 1.01 | 8.97 B$ |

The latest earnings report for Q2 2024 showed EPS of $1.54, surpassing analyst expectations. Revenue also exceeded forecasts, reaching $9.47 billion. 

**5. Overall Analysis:**

PM is currently trading at an overbought level with a slightly positive PPO. While the recent earnings beat expectations, the stock is lagging behind the S&P 500 and shows potential for a short-term correction. The high expected return suggests potential long-term growth, but investors should be aware of the current overbought condition and consider the potential for a near-term correction.

**6. Recommendations:**

Investors should monitor the stock closely for any signs of a correction. This could be a good entry point for long-term investors, but it is important to exercise caution and consider the current overbought condition.  
